- Report
- August 2021
Global
From €3832EUR$3,990USD£3,299GBP
- Report
- August 2021
Europe
From €3285EUR$3,420USD£2,828GBP
- Report
- February 2021
Global
From €2843EUR$2,960USD£2,448GBP
- Report
- October 2018
- 50 Pages
Global
From €3357EUR$3,495USD£2,890GBP
- Report
- January 2023
- 52 Pages
Global
From €3837EUR$3,995USD£3,303GBP
- Report
- September 2022
- 160 Pages
Global
From €4562EUR$4,750USD£3,928GBP
- Report
- September 2022
- 342 Pages
Global
From €9124EUR$9,500USD£7,856GBP
- Book
- October 2021
- 400 Pages
- Report
- May 2021
- 77 Pages
Global
From €3200EUR$3,569USD£2,851GBP
- Report
- January 2024
- 104 Pages
Global
From €3500EUR$3,904USD£3,119GBP
- Report
- March 2022
- 98 Pages
Global
From €3500EUR$3,904USD£3,119GBP
- Report
- May 2021
- 89 Pages
Global
From €3200EUR$3,569USD£2,851GBP
- Report
- February 2024
- 87 Pages
Global
From €3500EUR$3,904USD£3,119GBP
- Report
- January 2024
- 40 Pages
United States
From €1052EUR$1,095USD£905GBP
- Report
- June 2023
- 132 Pages
Global
From €912EUR$950USD£786GBP
- Report
- June 2023
- 132 Pages
Global
From €912EUR$950USD£786GBP
The Obesity market is a therapeutic area that focuses on the treatment of obesity and related conditions. It includes a range of treatments, from lifestyle changes such as diet and exercise to medications and surgical interventions. The goal of these treatments is to reduce the risk of obesity-related health complications, such as type 2 diabetes, heart disease, and stroke.
The market is driven by a growing awareness of the health risks associated with obesity, as well as the increasing prevalence of the condition. Additionally, advances in medical technology have enabled more effective treatments for obesity, such as bariatric surgery.
Several companies are active in the Obesity market, including Novo Nordisk, Orexigen Therapeutics, Arena Pharmaceuticals, and Vivus. These companies are focused on developing treatments for obesity, ranging from lifestyle interventions to medications and surgical interventions. Show Less Read more